Last reviewed · How we verify
Bioequivalence of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference topical augmented betamethasone dipropionate augmented 0.05% cream in healthy, female subjects.
Details
| Lead sponsor | Padagis LLC |
|---|---|
| Status | COMPLETED |
| Enrolment | 116 |
| Start date | 2002-12 |
| Completion | 2003-01 |
Conditions
- Healthy
Interventions
- Betamethasone Dipropionate 0.05% Cream
Primary outcomes
- Vasoconstriction will be measured by the degree of skin blanching observed after treatment removal using a ChromaMeter. — Over the course of one day